Xiamen Amoytop Biotech Co., Ltd. (SHA:688278)
China
· Delayed Price · Currency is CNY 73.64
-0.95 (-1.27%)
Jun 6, 2025, 3:00 PM CST
Xiamen Amoytop Biotech Market Cap
Xiamen Amoytop Biotech has a market cap or net worth of 29.96 billion as of June 6, 2025. Its market cap has increased by 25.05% in one year.
Market Cap
29.96B
Enterprise Value
29.16B
Revenue
2.95B
Ranking
n/a
PE Ratio
34.13
Stock Price
73.64
Market Cap Chart
Since January 17, 2020, Xiamen Amoytop Biotech's market cap has increased from 14.36B to 29.96B, an increase of 108.61%. That is a compound annual growth rate of 14.62%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 6, 2025 | 29.96B | 0.37% |
| Dec 31, 2024 | 29.85B | 40.15% |
| Dec 29, 2023 | 21.30B | 34.47% |
| Dec 30, 2022 | 15.84B | 32.96% |
| Dec 31, 2021 | 11.91B | -14.13% |
| Dec 31, 2020 | 13.87B | -3.40% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Jiangsu Hengrui Medicine | 356.93B |
| Shenzhen Mindray Bio-Medical Electronics | 284.57B |
| WuXi AppTec | 184.51B |
| Zhangzhou Pientzehuang Pharmaceutical., | 122.65B |
| Sichuan Biokin Pharmaceutical | 122.55B |
| Aier Eye Hospital Group | 117.29B |
| Shanghai United Imaging Healthcare | 116.46B |
| Yunnan Baiyao Group Co.,Ltd | 100.54B |